Abstract:Finding local treatments for thoracic malignant tumors (primary/metastatic) for patients who cannot undergo surgery or radiotherapy (RT) is crucial. The purpose of this study was to ascertain the: safety and efficacy of radioactive iodine-125 seeds (RIS) implantation for treatment of thoracic tumors; relationship between different therapeutic doses, efficacy and side-effects. Inclusion criteria: (1) Primary or metastatic tumors of the chest with definite pathological diagnosis; (2) unable or unsuitable for surgery or radiotherapy; (3) tumor diameter < 7cm, with appropriate puncture path; (4) no bleeding tendency; (5) KPS > 70 score. All patients underwent preoperative planning design, 3D printing template design, and printing, CT-guided seeds implantation assisted by template and post-operative dosimetric verification. The prescribe dose was 80-170Gy. The patients were followed up regularly after treatment. The main outcome measures were local control rate and toxicity, and the secondary end-point was total survival. Short-term efficacy was evaluated based on RECIST criteria, and toxicity was evaluated based on CTCAE criteria. Statistical methods: Chi-square test was used to compare the rates. Kaplan-Meier method was used to analyze the local control rate and survival rate of patients. Log-rank test was used for univariate analysis and COX regression model was used for multivariate analysis. We enrolled 41 patients with lung cancer and 51 cases with metastatic lung cancer. Median lesion diameter was 5 cm. Median D90 was 142.6 Gy after postoperative dosimetry verification. Median follow-up was 10.7 months. OS at 1 year and 3 years was 59.7% and 22.2%, respectively. LC at 1 year and 3 years was 64.9% and 32.8%, respectively. Univariate analysis revealed LC to be associated with the target dose and lesion type. LC at 3 years for patients with D90 <140 Gy and D90 >140 Gy was 23.1% and 54.3%, respectively (p = 0.014) (Figure 3). LC of metastatic lung cancer was more favorable than that of primary lung cancer. LC was not associated with previous RT, lesion volume, or squamous cell carcinoma/adenocarcinoma (p>0.05). Multivariate analyses showed the dose and lesion type to be independent factors of LC (p<0.05). No factors were related to OS. Prevalence of pneumothorax and hemoptysis was 35.8% and 3.2%, respectively. Few cases of RT-related toxicities and side-effects were noted (Table). RIS implantation maybe a safe, efficacious palliative treatment for thoracic tumors. If patients have local treatment needs, surgery or RT is not available for various reasons, RIS implantation could be considered.Abstract 3119; Table 1Adverse reactionsAdverse reactionsCasesPercentageRadiation pneumonia (grade>=2)33.3Radiation esophagitis (grade>=2)22.2Esophageal fistula11.1Tracheal fistula22.2Radiation myelitis00.0Radiation skin reaction (grade>=2)55.4Chest-wall pain11.1Hemoptysis33.2Pneumothorax3435.8 Open table in a new tab

Safety and Efficacy of a 3D Printing Template Combined with CT-Guided Implantation of Radioactive 125 I Seeds for Treatment of Thoracic Malignancies: A Single-Center, Prospective, Phase-I Clinical Trial

Safety And Efficacy Of A 3d Printing Template Combined With Ct-Guided Implantation Of Radioactive I-125 Seeds For Treatment Of Thoracic Malignancies: A Single-Center, Prospective, Phase-I Clinical Trial

Radiation-related Adverse Effects of CT-guided Implantation of 125I Seeds for Thoracic Recurrent And/or Metastatic Malignancy

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

Safety and efficacy of 3D-printed templates assisted CT-guided radioactive iodine-125 seed implantation for the treatment of recurrent cervical carcinoma after external beam radiotherapy

Efficacy and dosimetric analysis of CT-guided 125I seed implantation assisted by 3D-printed coplanar template in the treatment of metastatic tumors of chest wall

Side effects of CT-guided implantation of 125 I seeds for recurrent malignant tumors of the head and neck assisted by 3D printing non co-planar template

Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety

Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies

The efficacy and dosimetry analysis of CT-guided 125I seed implantation assisted with 3D-printing non-co-planar template in locally recurrent rectal cancer

Dosimetry, Efficacy, and Safety of Three-Dimensional Printing Noncoplanar Template-Assisted and CT-guided 125I Seed Implantation for Recurrent Retroperitoneal Lymphatic Metastasis after External Beam Radiotherapy

Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma

Therapeutic Effect Analsysis of Ultrasound-Guided Radioactive 125I Seed Implantation in the Treatment of Hepatic Tumors at Dangerous Sites

Percutaneous Computed Tomography-Guided Permanent 125I Implantation As Therapy for Pulmonary Metastasis.

CT-guided Interstitial Implantation of ~(125)I Seed for Lung Cancer

Clinical efficacy of CT-guided ~(125)I seed implantation therapy for advanced lung cancer

Computed Tomography (CT)-guided Interstitial Permanent Implantation of 125I Seeds for Refractory Chest Wall Metastasis or Recurrence

Preliminary Clinical Efficacy of Iodine-125 Seed Implantation for the Treatment of Advanced Malignant Lung Tumors

The Clinical Results and Physical Dosimetry Study of 3D-Printing Template Assisted with CT-Guidance for 125I Seed Brachytherapy in Recurrent or Metastatic Gynecologic Carcinoma

Analysis on the Accuracy of CT-guided Radioactive I-125 Seed Implantation with 3D Printing Template Assistance in the Treatment of Thoracic Malignant Tumors.

The Dosimetry Evaluation of 3D Printing Non-Coplanar Template-Assisted CT-guided 125I Seed Stereotactic Ablation Brachytherapy for Pelvic Recurrent Rectal Cancer after External Beam Radiotherapy.